Detalhe da pesquisa
1.
Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal Antibodies.
Clin Infect Dis
; 74(9): 1706-1707, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34598278